Labor induction with double balloon catheter, oral misoprostol or both: a randomized controlled trial
In brief
Combining balloon and misoprostol shortened labor induction by 6 to 8 hours
In a randomized trial of 216 women, combining a cervical balloon with oral misoprostol cut median time from induction to delivery to 14.7 hours, compared with 20.7 hours with the balloon and 22.9 hours with misoprostol alone. Cesarean rates were similar, but early study stoppage limited the evidence on whether the faster inductions improve outcomes.
- Journal
- Archives of gynecology and obstetrics (Q1)
- Published
- 12 August 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Inna Bleicher, Dafna Ben Yehuda, Dmitry Basov, Mayson Einas Khniefes, Sharon Einav, Shlomi Sagi, et al.
- PMID
- 43002253
- DOI
- 10.1007/s00404-026-08526-9
Why clinicians should know about it
- Picked for Obstetrics and Gynecology (top studies of the week, 22 November 2026): Randomized comparison of term labour induction methods
Abstract
OBJECTIVE: To compare cesarean delivery rates and induction outcomes among women undergoing labor induction with a cervical ripening double balloon (DB), oral misoprostol (OM), or a combination of both (DOM). METHODS: This single-center randomized controlled trial included women with singleton term pregnancies, cephalic presentation, Bishop score ≤ 4, and intact membranes. Participants were randomized to DB for 6 h, oral misoprostol, or combined treatment. The primary outcome was cesarean delivery rate. Secondary outcomes included Bishop score after 6 h, time from induction to delivery, failed induction, and maternal and neonatal outcomes. Due to slow recruitment, the study was stopped early, and complete-case analysis was performed. RESULTS: A total of 216 participants were included in the analysis (DB n = 65, OM n = 75, DOM n = 76). Cesarean delivery rates were 20%, 11%, and 20% in the DB, OM, and DOM groups, respectively (p = 0.2). The combined treatment group demonstrated a significantly shorter induction-to-delivery interval (median 14.7 h vs 20.7 in DB [p = 0.006] and 22.9 h in OM [p < 0.001]); higher 6-h Bishop scores (median 6 vs 5 in DB [p = 0.012] and 4 in OM [p < 0.001]);and lower rates of failed induction (2.6% vs 18% in DB [p = 0.010] and 5.4% in OM [p = 0.4]). Maternal and neonatal outcomes were similar across groups. CONCLUSION: Despite limited power this study suggests that combined use of cervical ripening balloon and oral misoprostol shortens induction duration and improves early cervical ripening without increasing cesarean delivery rates. This approach may enhance the efficiency of labor induction. CLINICAL TRIAL REGIRSTRATION: Date of registration: 03-03-2019. Date of initial participant enrollment, July 1st, 2019. Clinical trial identification number #NCT03866772. URL of the registration site: https://clinicaltrials.gov/study/NCT03866772#study-overview.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.